<?xml version="1.0" encoding="UTF-8"?>
<p>Following a 2.5-day incubation period (range of 2–12 days) [
 <xref rid="B7-microorganisms-07-00133" ref-type="bibr">7</xref>,
 <xref rid="B162-microorganisms-07-00133" ref-type="bibr">162</xref>], the acute phase of CHIKV infection is characterized by a brutal onset of symptoms typically associated with fever, very severe polyarthralgia (“frightening in its severity” as first described by Robinson [
 <xref rid="B7-microorganisms-07-00133" ref-type="bibr">7</xref>]) with possible synovitis, and a delayed rash that is often pruriginous while rarely bullous [
 <xref rid="B128-microorganisms-07-00133" ref-type="bibr">128</xref>,
 <xref rid="B163-microorganisms-07-00133" ref-type="bibr">163</xref>,
 <xref rid="B164-microorganisms-07-00133" ref-type="bibr">164</xref>]. Less well-known, but commonly associated manifestations include headaches, gastrointestinal symptoms, and more rarely conjunctival hyperemia or lymphadenopathy. While in the earliest descriptions of the disease the hemorrhagic, severe or lethal cases were questioned because of co-circulation with dengue fever [
 <xref rid="B19-microorganisms-07-00133" ref-type="bibr">19</xref>,
 <xref rid="B129-microorganisms-07-00133" ref-type="bibr">129</xref>,
 <xref rid="B165-microorganisms-07-00133" ref-type="bibr">165</xref>,
 <xref rid="B166-microorganisms-07-00133" ref-type="bibr">166</xref>], it is now clearly established that CHIKV infection can carry potentially lethal neurologic and cardiologic involvement [
 <xref rid="B150-microorganisms-07-00133" ref-type="bibr">150</xref>,
 <xref rid="B152-microorganisms-07-00133" ref-type="bibr">152</xref>,
 <xref rid="B153-microorganisms-07-00133" ref-type="bibr">153</xref>] or be directly or indirectly linked to death, particularly in older patients with numerous comorbidities [
 <xref rid="B128-microorganisms-07-00133" ref-type="bibr">128</xref>,
 <xref rid="B150-microorganisms-07-00133" ref-type="bibr">150</xref>,
 <xref rid="B156-microorganisms-07-00133" ref-type="bibr">156</xref>,
 <xref rid="B167-microorganisms-07-00133" ref-type="bibr">167</xref>] or in neonates [
 <xref rid="B156-microorganisms-07-00133" ref-type="bibr">156</xref>,
 <xref rid="B157-microorganisms-07-00133" ref-type="bibr">157</xref>]. Overall, the global mortality rate is estimated at 0.01–0.1% [
 <xref rid="B32-microorganisms-07-00133" ref-type="bibr">32</xref>,
 <xref rid="B81-microorganisms-07-00133" ref-type="bibr">81</xref>,
 <xref rid="B119-microorganisms-07-00133" ref-type="bibr">119</xref>,
 <xref rid="B156-microorganisms-07-00133" ref-type="bibr">156</xref>].
</p>
